[ET Net News Agency, 5 January 2026] HANSOH PHARMA (03692) rose 3.3% to HK$37.66.
It hits an intra-day high of HK$37.66, breaking above the 100-D SMA of HK$37.378, and an intra-day low of HK$35.7. The total shares traded was 3 million, with a value of HK$109.78m. The active buy/sell ratio is 62:38, with net buying turnover of HK$24.74m. BARCLAYS CAPITAL ASIA accounts for greatest net responsive buying turnover of HK$1.12m, with volume weighted average price of HK$36.687. HSBC SEC BRO (ASIA) accounts for greatest net responsive selling turnover of HK$7.27m, with volume weighted average price of HK$36.549. The stock has risen a combined 4.4% over the past 2 consecutive trading days.
The Hang Seng Index now rose 78 points, or 0.3% to 26,416.
Basic Information| Nominal | 37.660 | % Chg | +3.35% |
| High | 37.660 | Low | 35.700 |
| Shares Tr | 3m | Turnover | 109.78m |
| 10-D SMA | 37.462 | %H.V | 34.645 |
| 20-D SMA | 39.388 | VWAP | 36.570 |
| 50-D SMA | 38.371 | RSI14 | 44.114 |
Status: Breaking above the 100-D SMA, active buy/sell ratio is 62:38, with net buying turnover of HK$24.74m, rising a combined 4.4% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 37.66 | +3.35 |
| GRAND PHARMA (00512) | 7.89 | +1.15 |
| CSPC PHARMA (01093) | 8.79 | +3.66 |
| SINO BIOPHARM (01177) | 6.45 | +1.42 |
| HENGRUI PHARMA (01276) | 76.15 | +2.77 |
| INNOVENT BIO (01801) | 83.10 | +5.46 |
| WUXI BIO (02269) | 33.24 | +2.15 |
| WUXI APPTEC (02359) | 104.80 | +3.76 |
| BEONE MEDICINES (06160) | 195.50 | +5.96 |
| AKESO (09926) | 117.50 | +3.71 |
(ed)
